Lung nodule AI developer RevealDx has appointed Ryan Brevard, MD, as director of clinical programs and David Austin as vice president of sales.
Brevard, an emergency medicine physician who has served as a medical advisor to the company for four years, will work with hospitals and radiology groups to build lung nodule programs around the company’s RevealAI-Lung software. Austin previously held senior sales leadership roles at Siemens Healthineers and Hologic.
The appointments follow the company’s receipt of clearance from the U.S. Food and Drug Administration (FDA) in February for nodule risk assessment with RevealAI-Lung.
